GLP-1 Medications8 min read·Published July 8, 2026

Can You Get Mounjaro Without a Doctor’s Prescription?

What is legal in the U.S., why tirzepatide needs medical supervision, and how in-person and telehealth prescriptions work.

ByDr. Marcus Holloway
Clinically reviewed by Dr. Anika Rao
Can You Get Mounjaro Without a Doctor’s Prescription?

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

No. Mounjaro (tirzepatide, a GLP-1/GIP dual receptor agonist made by Eli Lilly) is prescription-only in the United States. You cannot legally buy it over the counter, from a pharmacy without a prescription, or from an online seller that skips a clinical evaluation. A licensed clinician must review your health history and issue a valid prescription first [1].

Can you get Mounjaro without a doctor’s prescription?

No. Mounjaro is a prescription drug, and a U.S. pharmacy cannot legally dispense it without a valid prescription from an authorized clinician. That rule applies whether the prescription comes from an in-person visit or a telehealth evaluation [1][7].

The same rule applies to Zepbound (tirzepatide, a GLP-1/GIP dual receptor agonist brand approved for chronic weight management). Zepbound also requires a prescription and medical screening before use [2].

A “no prescription” offer for Mounjaro, tirzepatide, compounded tirzepatide, Ozempic (semaglutide, a GLP-1 receptor agonist), or compounded semaglutide is a red flag. These medicines can cause side effects, interact with other drugs, and may be unsafe for some people [1][2][3][8].

Why is Mounjaro prescription-only?

FDA scheduling and legal status

Tirzepatide is not a controlled substance, so DEA controlled-substance scheduling is not the main issue. It is prescription-only because FDA-approved labeling limits dispensing to use under a licensed prescriber’s order, and pharmacies must follow federal and state prescription rules [1][7].

The FDA approved Mounjaro for adults with type 2 diabetes as an add-on to diet and exercise to improve blood sugar control. That diabetes indication is different from Zepbound’s FDA-approved weight management indication [1][2].

Safety reasons for medical supervision

Tirzepatide can improve A1C and body weight in clinical trials, but the same studies and FDA labels also report side effects such as nausea, diarrhea, vomiting, constipation, abdominal pain, and reduced appetite [1][2][4][5]. A clinician checks whether the likely benefit is worth those risks for your situation.

In the SURPASS-2 trial, adults with type 2 diabetes received tirzepatide 5 mg, 10 mg, or 15 mg once weekly, or semaglutide 1 mg once weekly; tirzepatide lowered A1C more than semaglutide 1 mg, while gastrointestinal side effects were common [4]. Individual results vary.

Medical review is also needed because tirzepatide can increase the risk of low blood sugar when used with insulin or sulfonylureas, may affect kidney function during severe dehydration, and has warnings for gallbladder disease, pancreatitis, and severe stomach emptying problems [1][2].

Boxed warning and contraindications

Mounjaro and Zepbound carry a boxed warning about thyroid C-cell tumors seen in rodent studies. The labels say tirzepatide is contraindicated in people with a personal or family history of medullary thyroid carcinoma, also called MTC, or multiple endocrine neoplasia syndrome type 2, called MEN2 [1][2].

Pregnancy also matters. The Zepbound label says weight loss offers no benefit during pregnancy and may harm a fetus, and the Mounjaro label includes pregnancy safety information that should be reviewed with a clinician before use [1][2].

Is Mounjaro sold over the counter anywhere?

U.S. pharmacy rules

Mounjaro is not available over the counter in the United States. The FDA-approved label describes Mounjaro as a prescription medicine, and pharmacies should not dispense it without a valid prescription order for that patient [1][7].

Some states allow pharmacists to prescribe limited medicines under specific protocols. That does not make Mounjaro an over-the-counter drug. For tirzepatide, the safe and legal path is a licensed prescriber’s evaluation before a pharmacy dispenses it [1][7].

Buying from overseas or gray-market sellers

Buying “Mounjaro” from an overseas or gray-market website can expose you to counterfeit, contaminated, or incorrectly labeled products. The FDA has warned consumers about unapproved GLP-1 products and adverse events with some compounded or illegally marketed semaglutide products; similar caution applies to injectable metabolic medicines sold outside normal pharmacy channels [8][9].

A low price is not proof that a product is real. A legitimate pharmacy should require a prescription, provide a way to contact a pharmacist, and be licensed to operate where you live [8].

What about compounded tirzepatide — do you still need a prescription?

Yes. Compounded tirzepatide from a licensed 503A pharmacy still requires a valid prescription. Compounded tirzepatide is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness, or quality before they are dispensed [6].

How 503A compounding pharmacies work

A 503A compounding pharmacy makes a medication for an individual patient based on a valid prescription when legal requirements are met. Compounding can be appropriate in specific cases, but it is not the same as an FDA-approved brand-name product [6].

This matters because tirzepatide’s benefits in diabetes and weight management were studied using specific manufactured products, while compounded versions may vary by pharmacy. Side effects and contraindications still apply because the active drug is intended to act on the same GLP-1 and GIP pathways [1][2][4][5][6].

Current FDA shortage status for tirzepatide

FDA shortage status can affect when certain copies of commercially available drugs may be compounded. The FDA Drug Shortages database is the source to check, and FDA has stated that compounding copies of commercially available drugs is limited by federal law except in specific circumstances [6][10].

Who qualifies for a Mounjaro or tirzepatide prescription?

Type 2 diabetes indication

Mounjaro is FDA-approved for adults with type 2 diabetes to improve blood sugar control along with diet and exercise [1]. In the SURPASS-2 trial, tirzepatide lowered A1C more than semaglutide 1 mg in adults with type 2 diabetes, but gastrointestinal side effects were common and the study excluded some higher-risk patients [4]. Individual results vary.

A clinician may review your A1C, current diabetes medicines, kidney function, history of pancreatitis or gallbladder disease, and risk of hypoglycemia before prescribing. This review is part of why a prescription is required [1][11].

Off-label use for weight loss

Using Mounjaro specifically for weight loss is off-label because Mounjaro’s FDA-approved indication is type 2 diabetes. Zepbound is the tirzepatide brand FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition, as defined in its label [2].

In the SURMOUNT-1 trial, adults with obesity or overweight without diabetes received tirzepatide 5 mg, 10 mg, or 15 mg once weekly, or placebo, for 72 weeks; tirzepatide led to significant weight loss, while nausea, diarrhea, and constipation were common [5]. Individual results vary.

Who should not take tirzepatide

Tirzepatide should not be used by people with a personal or family history of MTC or by people with MEN2. People who are pregnant, planning pregnancy, breastfeeding, or who have a history of pancreatitis, severe gastrointestinal disease, gallbladder disease, kidney issues, or certain diabetes medicines need careful clinician review [1][2].

How do you actually get a prescription — in person vs. telehealth?

Seeing your primary care doctor

Your primary care clinician may be able to evaluate you for tirzepatide within one visit, depending on your history and available labs. They may ask about your diagnosis, weight history, current medicines, pregnancy plans, family history of thyroid cancer, and prior side effects from GLP-1 medicines [1][2][11].

Benefits of in-person care include access to a full exam and local lab follow-up. Limits can include appointment wait times, insurance steps, and pharmacy availability [11].

Using a telehealth provider

Telehealth can also be a legal way to get evaluated for Mounjaro, Zepbound, or compounded tirzepatide when the clinician is licensed and follows federal and state prescribing rules. Telehealth should still include a real medical history review, safety screening, and a pharmacy that requires a valid prescription [7][8].

Be cautious with “same-day Mounjaro” promises. A fast evaluation is not the same as an automatic prescription. A clinician may decide tirzepatide is not appropriate or may recommend a different treatment based on your risks [1][2].

What the clinical evaluation covers

  • Reason for treatment, such as type 2 diabetes or weight management eligibility [1][2]
  • Current medications, especially insulin, sulfonylureas, and medicines affected by delayed stomach emptying [1][2]
  • History of pancreatitis, gallbladder disease, kidney problems, severe gastrointestinal disease, MTC, or MEN2 [1][2]
  • Pregnancy status, pregnancy plans, and breastfeeding [1][2]
  • Recent labs when clinically needed, such as A1C or kidney function [11]
  • Side effects to watch for and when to seek urgent care [1][2]

How Chia fits in: getting tirzepatide through a clinician-reviewed telehealth path

If you are considering a legal online path, Chia is one option among licensed telehealth providers that offers clinician-reviewed evaluations for compounded GLP-1 medications, including compounded tirzepatide when appropriate and legally available through licensed 503A pharmacy partners. Compounded GLP-1s are not FDA-approved, still require a prescription, and are not right for everyone [6].

A responsible telehealth path should not promise approval. It should screen for contraindications, explain side effects, review costs, and send prescriptions only when a licensed clinician decides the medication is appropriate [1][2][7].

3-min quiz

Considering a prescription evaluation?

A licensed clinician can review your health history, goals, and safety risks to see whether a tirzepatide option may be appropriate.

What does a legitimate Mounjaro or tirzepatide prescription cost?

Cost for tirzepatide depends on the product, insurance, pharmacy, and whether the medication is brand-name or compounded. A lower price should never come from skipping the prescription or pharmacy safety steps [6][8].

OptionFDA statusPrescription needed?Common cost factorsKey safety notes
Mounjaro brand tirzepatideFDA-approved for adults with type 2 diabetes [1]YesInsurance coverage, prior authorization, deductible, manufacturer programs, pharmacy availabilityBoxed warning for thyroid C-cell tumors; contraindicated with MTC or MEN2; GI side effects are common [1]
Zepbound brand tirzepatideFDA-approved for chronic weight management in eligible adults [2]YesInsurance coverage for obesity care, prior authorization, cash price, manufacturer programsSame active drug class risks; weight management use requires screening and monitoring [2]
Compounded tirzepatide via 503A pharmacyNot FDA-approved; may be available only when legal compounding requirements are met [6]YesTelehealth or clinic fee, pharmacy price, formulation, state rules, availabilityFDA does not review compounded drugs for safety, effectiveness, or quality before dispensing [6]
Ozempic / semaglutide comparisonOzempic is FDA-approved for type 2 diabetes; other semaglutide brands have other indications [3]YesInsurance indication, plan rules, pharmacy stock, brand versus compounded optionsGLP-1 side effects and contraindications differ by label and patient history [3]

The cheapest legal route is usually the one that matches your medical indication and insurance rules, not the one that avoids a clinician. For some people, that may be an insurance-covered brand product; for others, it may be a cash-pay clinical visit and a legally dispensed compounded option [6][8].

Red flags: how to spot an illegal “no prescription” Mounjaro seller

No-prescription Mounjaro offers are not a shortcut; they are a safety risk. FDA and pharmacy groups warn that unsafe online pharmacies may sell counterfeit, contaminated, expired, or incorrectly dosed medicines [8][9].

  • The site says no prescription or health review is needed.
  • The product is labeled “research use only” but sold for human injection.
  • The seller will not name the dispensing pharmacy or pharmacist.
  • There is no U.S. pharmacy license information.
  • The site ships from outside normal pharmacy channels or asks for payment by crypto, wire, or gift card.
  • The product is much cheaper than expected and the seller claims it is “the same as Mounjaro” without a prescription.
  • The seller gives dosing instructions without a clinician evaluation.

A legitimate path should include a licensed clinician, a valid prescription, a licensed pharmacy, clear labeling, and a way to report side effects or ask questions [7][8].

3-min quiz

Talk with a clinician about legal options

If you are unsure whether tirzepatide or another GLP-1 option fits your health history, a clinician-reviewed evaluation can help clarify the next step.

References

  1. 1.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. 2025.
  2. 2.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2025.
  3. 3.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. 2025.
  4. 4.Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine. 2021.
  5. 5.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022.
  6. 6.U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers. 2024.
  7. 7.U.S. Congress. Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 353(b): Exemptions and consideration for certain drugs, prescription requirements. 2024.
  8. 8.National Association of Boards of Pharmacy. Safe pharmacy: Buying medicine online. 2024.
  9. 9.U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. 2024.
  10. 10.U.S. Food and Drug Administration. FDA Drug Shortages database. 2026.
  11. 11.American Diabetes Association Professional Practice Committee. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes. Diabetes Care. 2025.

About this article

Dr. Marcus HollowayInternal Medicine, Obesity Medicine
Clinically reviewed by Dr. Anika RaoEndocrinology, MD

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides